Recent Finacing
Recent Raise
NeoSync develops NEST, a clinical-stage, non-invasive EEG-synchronized TMS platform delivering low-energy, 30-minute daily, alpha-frequency personalized neuromodulation for major depressive disorder and other CNS diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor